Kinlin L. Chao

Kinlin L. Chao

Auto-generated profile, based on publicly available information

Kinlin L. Chao

Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JGJohnathan Guest
Johnathan Guest
RWRuixue Wang
Ruixue Wang
KEKhadija H. Elkholy
Khadija H. Elkholy
ACAndrezza Chagas
Andrezza Chagas
KCKinlin L. Chao
Kinlin L. Chao
TFThomas Fuerst
Thomas Fuerst
Significance: Hepatitis C virus infects 1% of the world’s population, with no vaccine currently available. One vaccine candidate is the membrane-associated E1E2 envelope glycoprotein which has been used in clinical studies. However, a major challenge to both structural studies and rational vaccine design is high-yield production of homogenous E1E2. Production of E1E2 liberated from the membrane with native structure and antigenicity would thus represent a major advance. We describe the design and validation of a soluble, secreted E1E2 (sE1E2) antigen in which a scaffold replaces its transmembrane domains and enforces assembly. High-affinity sE1E2 binding to broadly neutralizing antibodies and to its receptor CD81, along with robust immunogenicity, makes this a promising platform for high-resolution structural characterization and vaccine development.

1 March 2023 in Biomolecular NMR Assignments
Verified
Journal Article
Closed access
PDF file
TSTsega L. Solomon
Tsega L. Solomon
KCKinlin Chao
Kinlin Chao
GGGenevieve Gingras
Genevieve Gingras
YAYves Aubin
Yves Aubin
WOWilliam O'Dell
William O'Dell
RBRobert Brinson
Robert Brinson